SAN FRANCISCO--(BUSINESS WIRE)--IPM.ai, part of Real Chemistry and a leader in uncovering undiagnosed and misdiagnosed patients for specialty and rare disease via machine learning and artificial ...
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. Recognition underscores IPM.ai's AI-powered approach to finding undiagnosed and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results